Thus, we confirmed that even when CB-839’s BBB permeability was not a limiting factor, the synergy between HEX and CB-839 that we observed in in vitro experiments could not be recapitulated in in vivo subcutaneous tumor models and, at best, the combination treatment exhibited an additive interaction. This evidence concerns the gene HHEX and neoplasm.